• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PXC201200
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 05/12/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Please note that this event was also reported in medwatch(es) # 3013164176-2020-00073 and # 2953161-2020-00013.Details of the event required a separate medwatch submission for component identified; as such this medwatch is being submitted.According to the instructions for use (ifu) for the gore® excluder® aaa endoprosthesis; adverse events that may occur include, but are not limited to: endoleak, a review of the manufacturing records for the device(s) verified that the lot(s) met all pre-release specifications.
 
Event or Problem Description
On (b)(6) 2012, this patient underwent endovascular treatment of an abdominal aortic aneurysm measuring approximately 45mm in diameter, and was implanted with gore® excluder® aaa endoprosthesis.In the beginning of (b)(6) 2020, follow-up imaging revealed aneurysm enlargement to approximately 60 mm in diameter and a type ii endoleak from the l4 lumbar artery.Additionally, a proximal type i endoleak was determined along with a type iii endoleak due to component disconnect of the contralateral leg component from the contralateral gate.On (b)(6) 2020, a reintervention was performed and an endurant cuff was placed to treat the proximal type i endoleak, and a contralateral leg component was placed to treat and reline the type iii endoleak.No treatment for the type ii endoleak was performed but future treatment is planned.The type i endoleak was reported to have not been resolved by placement of the endurant cuff.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10108639
Report Number2017233-2020-00392
Device Sequence Number3406069
Product Code MIH
UDI-Device Identifier00733132610044
UDI-Public00733132610044
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/30/2014
Device Model NumberPXC201200
Device Catalogue NumberPXC201200
Device Lot Number9892109
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date06/02/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other; Required Intervention;
Patient Age82 YR
-
-